INDIANAPOLIS, May 29 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) announced today that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of ALIMTA® (pemetre…
Biopharmaceuticasl, Oncology, Regulatory
Eli Lilly, ALIMTA, pemetrexed, NSCLC

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer”
Leave a Comment